216 related articles for article (PubMed ID: 24572783)
21. Transduction efficiency of neurons and glial cells by AAV-1, -5, -9, -rh10 and -hu11 serotypes in rat spinal cord following contusion injury.
Petrosyan HA; Alessi V; Singh V; Hunanyan AS; Levine JM; Arvanian VL
Gene Ther; 2014 Dec; 21(12):991-1000. PubMed ID: 25119378
[TBL] [Abstract][Full Text] [Related]
22. Intravenous administration of the adeno-associated virus-PHP.B capsid fails to upregulate transduction efficiency in the marmoset brain.
Matsuzaki Y; Konno A; Mochizuki R; Shinohara Y; Nitta K; Okada Y; Hirai H
Neurosci Lett; 2018 Feb; 665():182-188. PubMed ID: 29175632
[TBL] [Abstract][Full Text] [Related]
23. The advent of AAV9 expands applications for brain and spinal cord gene delivery.
Dayton RD; Wang DB; Klein RL
Expert Opin Biol Ther; 2012 Jun; 12(6):757-66. PubMed ID: 22519910
[TBL] [Abstract][Full Text] [Related]
24. Intramuscular scAAV9-SMN injection mediates widespread gene delivery to the spinal cord and decreases disease severity in SMA mice.
Benkhelifa-Ziyyat S; Besse A; Roda M; Duque S; Astord S; Carcenac R; Marais T; Barkats M
Mol Ther; 2013 Feb; 21(2):282-90. PubMed ID: 23295949
[TBL] [Abstract][Full Text] [Related]
25. A Safe and Reliable Technique for CNS Delivery of AAV Vectors in the Cisterna Magna.
Taghian T; Marosfoi MG; Puri AS; Cataltepe OI; King RM; Diffie EB; Maguire AS; Martin DR; Fernau D; Batista AR; Kuchel T; Christou C; Perumal R; Chandra S; Gamlin PD; Bertrand SG; Flotte TR; McKenna-Yasek D; Tai PWL; Aronin N; Gounis MJ; Sena-Esteves M; Gray-Edwards HL
Mol Ther; 2020 Feb; 28(2):411-421. PubMed ID: 31813800
[TBL] [Abstract][Full Text] [Related]
26. Efficient retrograde neuronal transduction utilizing self-complementary AAV1.
Hollis ER; Kadoya K; Hirsch M; Samulski RJ; Tuszynski MH
Mol Ther; 2008 Feb; 16(2):296-301. PubMed ID: 18223548
[TBL] [Abstract][Full Text] [Related]
27. Intravascular AAV9 Administration for Delivering RNA Silencing Constructs to the CNS and Periphery.
Dufour BD; McBride JL
Methods Mol Biol; 2016; 1364():261-75. PubMed ID: 26472457
[TBL] [Abstract][Full Text] [Related]
28. The AAV9 Variant Capsid AAV-F Mediates Widespread Transgene Expression in Nonhuman Primate Spinal Cord After Intrathecal Administration.
Beharry A; Gong Y; Kim JC; Hanlon KS; Nammour J; Hieber K; Eichler F; Cheng M; Stemmer-Rachamimov A; Stankovic KM; Welling DB; Ng C; Maguire CA
Hum Gene Ther; 2022 Jan; 33(1-2):61-75. PubMed ID: 34128391
[TBL] [Abstract][Full Text] [Related]
29. Widespread transduction of astrocytes and neurons in the mouse central nervous system after systemic delivery of a self-complementary AAV-PHP.B vector.
Rincon MY; de Vin F; Duqué SI; Fripont S; Castaldo SA; Bouhuijzen-Wenger J; Holt MG
Gene Ther; 2018 Apr; 25(2):83-92. PubMed ID: 29523880
[TBL] [Abstract][Full Text] [Related]
30. Gene therapy for the CNS using AAVs: The impact of systemic delivery by AAV9.
Saraiva J; Nobre RJ; Pereira de Almeida L
J Control Release; 2016 Nov; 241():94-109. PubMed ID: 27637390
[TBL] [Abstract][Full Text] [Related]
31. Glial promoter selectivity following AAV-delivery to the immature brain.
von Jonquieres G; Mersmann N; Klugmann CB; Harasta AE; Lutz B; Teahan O; Housley GD; Fröhlich D; Krämer-Albers EM; Klugmann M
PLoS One; 2013; 8(6):e65646. PubMed ID: 23799030
[TBL] [Abstract][Full Text] [Related]
32. Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9.
ElMallah MK; Falk DJ; Lane MA; Conlon TJ; Lee KZ; Shafi NI; Reier PJ; Byrne BJ; Fuller DD
Hum Gene Ther Methods; 2012 Apr; 23(2):148-56. PubMed ID: 22693957
[TBL] [Abstract][Full Text] [Related]
33. Preclinical differences of intravascular AAV9 delivery to neurons and glia: a comparative study of adult mice and nonhuman primates.
Gray SJ; Matagne V; Bachaboina L; Yadav S; Ojeda SR; Samulski RJ
Mol Ther; 2011 Jun; 19(6):1058-69. PubMed ID: 21487395
[TBL] [Abstract][Full Text] [Related]
34. Widespread neuron-specific transgene expression in brain and spinal cord following synapsin promoter-driven AAV9 neonatal intracerebroventricular injection.
McLean JR; Smith GA; Rocha EM; Hayes MA; Beagan JA; Hallett PJ; Isacson O
Neurosci Lett; 2014 Jul; 576():73-8. PubMed ID: 24882721
[TBL] [Abstract][Full Text] [Related]
35. Targeted gene delivery to the enteric nervous system using AAV: a comparison across serotypes and capsid mutants.
Benskey MJ; Kuhn NC; Galligan JJ; Garcia J; Boye SE; Hauswirth WW; Mueller C; Boye SL; Manfredsson FP
Mol Ther; 2015 Mar; 23(3):488-500. PubMed ID: 25592336
[TBL] [Abstract][Full Text] [Related]
36. Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.
Foust KD; Nurre E; Montgomery CL; Hernandez A; Chan CM; Kaspar BK
Nat Biotechnol; 2009 Jan; 27(1):59-65. PubMed ID: 19098898
[TBL] [Abstract][Full Text] [Related]
37. Rescue of amyotrophic lateral sclerosis phenotype in a mouse model by intravenous AAV9-ADAR2 delivery to motor neurons.
Yamashita T; Chai HL; Teramoto S; Tsuji S; Shimazaki K; Muramatsu S; Kwak S
EMBO Mol Med; 2013 Nov; 5(11):1710-9. PubMed ID: 24115583
[TBL] [Abstract][Full Text] [Related]
38. Intrathecal sc-AAV9-CB-GFP: Systemic Distribution Predominates Following Single-Dose Administration in Cynomolgus Macaques.
Meseck EK; Guibinga G; Wang S; McElroy C; Hudry E; Mansfield K
Toxicol Pathol; 2022 Jun; 50(4):415-431. PubMed ID: 35658751
[TBL] [Abstract][Full Text] [Related]
39. Physical positioning markedly enhances brain transduction after intrathecal AAV9 infusion.
Castle MJ; Cheng Y; Asokan A; Tuszynski MH
Sci Adv; 2018 Nov; 4(11):eaau9859. PubMed ID: 30443600
[TBL] [Abstract][Full Text] [Related]
40. Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.
Naidoo J; Stanek LM; Ohno K; Trewman S; Samaranch L; Hadaczek P; O'Riordan C; Sullivan J; San Sebastian W; Bringas JR; Snieckus C; Mahmoodi A; Mahmoodi A; Forsayeth J; Bankiewicz KS; Shihabuddin LS
Mol Ther; 2018 Oct; 26(10):2418-2430. PubMed ID: 30057240
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
